Associated Banc Corp Novartis Ag Transaction History

Associated Banc Corp

  • $3.64 Billion
  • Q3 2025

A detailed history of Associated Banc Corp transactions in Novartis Ag stock. As of the latest transaction made, Associated Banc Corp holds 7,356 shares of NVS stock, worth $967,681. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,356
Previous 8,101 9.2%
Holding current value
$967,681
Previous $980,000 3.78%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025
SELL
$113.5 - $129.73 $84,557 - $96,648
-745 Reduced 9.2%
7,356 $943,000
Q2 2025

Aug 12, 2025
SELL
$101.96 - $121.01 $22,839 - $27,106
-224 Reduced 2.69%
8,101 $980,000
Q1 2025

May 09, 2025
SELL
$97.14 - $115.57 $16,028 - $19,069
-165 Reduced 1.94%
8,325 $928,000
Q4 2024

Feb 10, 2025
SELL
$96.78 - $117.18 $31,163 - $37,731
-322 Reduced 3.65%
8,490 $826,000
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $4,245 - $4,835
-40 Reduced 0.45%
8,812 $1.01 Million
Q2 2024

Aug 01, 2024
BUY
$92.57 - $107.37 $12,404 - $14,387
134 Added 1.54%
8,852 $942,000
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $9,812 - $11,172
-103 Reduced 1.17%
8,718 $843,000
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $20,391 - $22,440
-221 Reduced 2.44%
8,821 $890,000
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $22,735 - $25,231
-240 Reduced 2.59%
9,042 $921,000
Q2 2023

Aug 07, 2023
SELL
$92.52 - $104.91 $7,216 - $8,182
-78 Reduced 0.83%
9,282 $936,000
Q1 2023

May 09, 2023
BUY
$80.03 - $92.81 $14,805 - $17,169
185 Added 2.02%
9,360 $861,000
Q4 2022

Feb 10, 2023
BUY
$75.55 - $92.52 $2,039 - $2,498
27 Added 0.3%
9,175 $832,000
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $16,041 - $18,760
-215 Reduced 2.3%
9,148 $695,000
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $34,704 - $40,406
-431 Reduced 4.4%
9,363 $792,000
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $33,966 - $38,422
-424 Reduced 4.15%
9,794 $859,000
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $9,962 - $11,016
-125 Reduced 1.21%
10,218 $894,000
Q3 2021

Nov 08, 2021
SELL
$81.78 - $95.14 $29,113 - $33,869
-356 Reduced 3.33%
10,343 $845,000
Q2 2021

Aug 11, 2021
SELL
$85.24 - $94.15 $145,163 - $160,337
-1,703 Reduced 13.73%
10,699 $977,000
Q1 2021

May 05, 2021
BUY
$83.5 - $98.47 $73,062 - $86,161
875 Added 7.59%
12,402 $1.02 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $20,844 - $25,212
-267 Reduced 2.26%
11,527 $1.09 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $57,169 - $63,336
-696 Reduced 5.57%
11,794 $1.03 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $1,618 - $1,822
-20 Reduced 0.16%
12,490 $1.09 Million
Q1 2020

May 14, 2020
BUY
$70.67 - $99.01 $75,616 - $105,940
1,070 Added 9.35%
12,510 $1.03 Million
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $9,700 - $10,967
-115 Reduced 1.0%
11,440 $1.08 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $55,943 - $61,646
-654 Reduced 5.36%
11,555 $1 Million
Q2 2019

Aug 06, 2019
SELL
$75.4 - $92.8 $50,065 - $61,619
-664 Reduced 5.16%
12,209 $1.12 Million
Q1 2019

May 07, 2019
SELL
$75.32 - $86.15 $14,310 - $16,368
-190 Reduced 1.45%
12,873 $1.24 Million
Q4 2018

Feb 13, 2019
BUY
$73.66 - $82.02 $7,586 - $8,448
103 Added 0.79%
13,063 $1.12 Million
Q3 2018

Nov 07, 2018
SELL
$66.94 - $77.43 $667,525 - $772,131
-9,972 Reduced 43.49%
12,960 $1.12 Million
Q2 2018

Aug 07, 2018
BUY
$64.91 - $73.36 $1.49 Million - $1.68 Million
22,932 New
22,932 $1.73 Million

Others Institutions Holding NVS

# of Institutions
1,601
Shares Held
137M
Call Options Held
1.53M
Put Options Held
2.22M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email